RxDoctor Payments Data

Amy Davis, APRN

Adult Health · New Haven, CTNPI 1922044155

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 348 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,292 and has fallen 96.7% since, to $75 in 2025. Among adult health clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,380in general payments, 2019–2025

Across 348 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • LEO Pharma Inc.$913
  • Pfizer$573
  • Sun Pharmaceutical Industries Inc.$552
  • Incyte Corporation$351
  • Amgen$310
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$6,365100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,380 in reported general payments places this provider in the 90th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut

Medicare billing

Part B allowed, 2024
$70,380
Medicare patients
447
Services billed
1,075

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tacrolimus90$13,077
Halobetasol Propionate103$4,522
Calcipotriene19$3,659
CiclopiroxCiclopirox Olamine65$2,788
Metronidazole65$2,704
Clobetasol Propionate57$2,227
Clindamycin Phosphate53$2,185
Fluorouracil25$2,156
Doxycycline Hyclate53$2,134
Ketoconazole174$1,982
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc48$1,807
Azelaic Acid16$1,715
Betamethasone Dipropionate33$877
Triamcinolone Acetonide80$797
Ciclopirox29$707

Paid to pharmacies, not to this prescriber.

Other adult health in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →